Evidence map›Paper›PMID 26060253›Full record

ArticleThe Journal of biological chemistry2015

IPO3-mediated Nonclassical Nuclear Import of NF-κB Essential Modulator (NEMO) Drives DNA Damage-dependent NF-κB Activation.

Byounghoon Hwang, Kevin McCool, Jun Wan, Shelly M Wuerzberger-Davis, Edmond W K Young, Eun Young Choi, Gino Cingolani, Beth A Weaver, Shigeki Miyamoto

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in immunology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Byounghoon HwangDepartment of Oncology, University of Wisconsin, Madison, Wisconsin.
Kevin McCoolDepartment of Oncology, University of Wisconsin, Madison, Wisconsin; Molecular and Cellular Pharmacology Program, University of Wisconsin, Madison, Wisconsin.
Jun WanDepartment of Cell and Regenerative Biology, University of Wisconsin, Madison, Wisconsin.
Shelly M Wuerzberger-DavisDepartment of Oncology, University of Wisconsin, Madison, Wisconsin; University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin.
Edmond W K YoungDepartment of Mechanical and Industrial Engineering and Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G8, Canada.
Eun Young ChoiDepartment of Oncology, University of Wisconsin, Madison, Wisconsin.
Gino CingolaniDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
Beth A WeaverDepartment of Cell and Regenerative Biology, University of Wisconsin, Madison, Wisconsin; University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin.
Shigeki MiyamotoDepartment of Oncology, University of Wisconsin, Madison, Wisconsin; University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin. Electronic address: smiyamot@wisc.edu.
University of Wisconsin–Madison · USUniversity of Wisconsin Carbone Cancer Center · USThomas Jefferson University · USUniversity of Toronto · CA

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
Regulation of NEMO modifications in radiation-induced NF-kB signalingR01CA077474 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MIYAMOTO, SHIGEKI · 2000 to 2014
$4.0M
Mitosis, Aneuploidy and CancerR01CA140458 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI WEAVER, BETH A · 2011 to 2015
$1.5M
Regulation of NF-kappaB by Small Ubiquitin-Like ModifiersR01GM083681 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MIYAMOTO, SHIGEKI · 2010 to 2013
$1.1M
NCI NIH HHS CA140458NCI NIH HHS P30 CA056036NCI NIH HHS R01 CA077474NCI NIH HHS R01 CA140458NCI NIH HHS R01 CA77474NIGMS NIH HHS GM083681NIGMS NIH HHS R01 GM083681NIGMS NIH HHS T32 GM008692
6 · The paper itself

Abstract

Activation of IκB kinase (IKK) and NF-κB by genotoxic stresses modulates apoptotic responses and production of inflammatory mediators, thereby contributing to therapy resistance and premature aging. We previously reported that genotoxic agents induce nuclear localization of NF-κB essential modulator (NEMO) via an undefined mechanism to arbitrate subsequent DNA damage-dependent IKK/NF-κB signaling. Here we show that a nonclassical nuclear import pathway via IPO3 (importin 3, transportin 2) mediates stress-induced NEMO nuclear translocation. We found putative nuclear localization signals in NEMO whose mutations disrupted stress-inducible nuclear translocation of NEMO and IKK/NF-κB activation in stably reconstituted NEMO-deficient cells. RNAi screening of both importin α and β family members, as well as co-immunoprecipitation analyses, revealed that a nonclassical importin β family member, IPO3, was the only importin that was able to associate with NEMO and whose reduced expression prevented genotoxic stress-induced NEMO nuclear translocation, IKK/NF-κB activation, and inflammatory cytokine transcription. Recombinant IPO3 interacted with recombinant NEMO but not the nuclear localization signal mutant version and induced nuclear import of NEMO in digitonin-permeabilized cells. We also provide evidence that NEMO is disengaged from IKK complex following genotoxic stress induction. Thus, the IPO3 nuclear import pathway is an early and crucial determinant of the IKK/NF-κB signaling arm of the mammalian DNA damage response.

Indexed as

DNA DamageActive Transport, Cell NucleusAmino Acid SequenceAnimalsbeta KaryopherinsCell LineHEK293 CellsHeLa CellsHumansI-kappa B KinaseMiceMolecular Sequence DataNF-kappa BNuclear Localization Signalsbeta KaryopherinsI-kappa B KinaseIKBKG protein, humanNF-kappa BNuclear Localization SignalsTNPO2 protein, humancancer therapyDNA damage responseinflammationNEMONF-kappaBnuclear translocation

Identifiers

PMID26060253
PMCPMC4505044
OpenAlexW1448641573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.